These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 13489704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
    JACQUEZ JA, HUTCHISON DJ.
    Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124
    [No Abstract] [Full Text] [Related]

  • 4. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM.
    Tex Rep Biol Med; 1957 May; 15(1):148-53. PubMed ID: 13409287
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH, KARNOFSKY DA.
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract] [Full Text] [Related]

  • 6. Effects on DON (6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo.
    KARNOFSKY DA, BEVELANDER G.
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):32-7. PubMed ID: 13518172
    [No Abstract] [Full Text] [Related]

  • 7. Potential anti-cancer agents--II. A proposed mechanism for the anti-cancer action of L-azaserine and 6-diazo-5-oxo-L-norleucine.
    BAKER BR.
    Biochem Pharmacol; 1959 Sep; 2():161-7. PubMed ID: 13795976
    [No Abstract] [Full Text] [Related]

  • 8. A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacety-L-serine on sarcoma 180.
    CLARKE DA, REILLY HC, STOCK CC.
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):653-71. PubMed ID: 24544598
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M, LAW LW.
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract] [Full Text] [Related]

  • 12. Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo.
    LEVENBERG B, MELNICK I, BUCHANAN JM.
    J Biol Chem; 1957 Mar; 225(1):163-76. PubMed ID: 13416227
    [No Abstract] [Full Text] [Related]

  • 13. The effect of 6-diazo-5-oxo-1-norleucine (DON) on pregnancy.
    JACKSON D, ROBSON JM, WANDER AC.
    J Endocrinol; 1959 Mar; 18(2):204-7. PubMed ID: 13641559
    [No Abstract] [Full Text] [Related]

  • 14. [Diazo derivates of amino acids and peptides as possible antineoplastic chemotherapeutic agents. III. Activity on Galliera sarcoma of 2 N-diazoacetyl derivatives of glycine in comparison with azaserine and DON].
    BALDINI L, BRAMBILLA G, MATTIOLI F.
    Boll Soc Ital Biol Sper; 1960 Nov 15; 36():1188-92. PubMed ID: 13686269
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease.
    MAGILL GB, MYERS WP, REILLY HC, PUTNAM RC, MAGILL JW, SYKES MP, ESCHER GC, KARNOFSKY DA, BURCHENAL JH.
    Cancer; 1957 Nov 15; 10(6):1138-50. PubMed ID: 13489662
    [No Abstract] [Full Text] [Related]

  • 16. Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan.
    TOMISEK AJ, REID MR, SKIPPER HE.
    Cancer Res; 1959 Jun 15; 19(5):489-93. PubMed ID: 13663035
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 6-diazo-5-oxo-L-norleucine on the incorporation of precursors into nucleic acids.
    BARCLAY RK, GARFINKEL E, PHILLIPPS MA.
    Cancer Res; 1962 Aug 15; 22():908-14. PubMed ID: 13864924
    [No Abstract] [Full Text] [Related]

  • 18. Mutagenicity of O-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L- norleucine (DON) in a soybean test system.
    Katoh Y, Maekawa M, Sano Y.
    Mutat Res; 1995 Mar 15; 342(1-2):37-41. PubMed ID: 7885392
    [Abstract] [Full Text] [Related]

  • 19. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. V. Microbiologic studies of mode of action.
    MAXWELL RE, NICKEL VS.
    Antibiot Chemother (Northfield); 1957 Feb 15; 7(2):81-9. PubMed ID: 24544268
    [No Abstract] [Full Text] [Related]

  • 20. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine.
    MOORE EC, LEPAGE GA.
    Cancer Res; 1957 Sep 15; 17(8):804-8. PubMed ID: 13460988
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.